This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D. Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. EJSOl 2013; 39: 4-16. doi: 10.1016/j.ejso.2012.08.016MaliBJarmTSnojMSersaGMiklavcicDAntitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis20133941610.1016/j.ejso.2012.08.016Open DOISearch in Google Scholar
Mir LM, Orlowski S, Belehradek J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. EJSO 1991; 27: 68-71. doi: 10.1016/0277-5379(91)90064-kMirLMOrlowskiSBelehradekJPaolettiCElectrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses199127687110.1016/0277-5379(91)90064-kOpen DOISearch in Google Scholar
Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874-82. doi: 10.1080/0284186X.2018.1454602GehlJSersaGMatthiessenLWMuirTSodenDOcchiniAUpdated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases2018578748210.1080/0284186X.2018.145460229577784Open DOISearch in Google Scholar
Campana LG, Clover AJ, Valpione S, Quaglino P, Gehl J, Kunte C, et al. Recommendations for improving the quality of reporting clinical electro-chemotherapy studies based on qualitative systematic review. Radiol Oncol 2016; 50: 1-13. doi: 10.1515/raon-2016-0006CampanaLGCloverAJValpioneSQuaglinoPGehlJKunteCRecommendations for improving the quality of reporting clinical electro-chemotherapy studies based on qualitative systematic review20165011310.1515/raon-2016-0006482533527069444Open DOISearch in Google Scholar
Campana LG, Miklavčič D, Bertino G, Marconato R, Valpione S, Imarisio I, et al. Electrochemotherapy of superficial tumors – Current status: Basic principles, operating procedures, shared indications, and emerging applications. Semin Oncol 2019; 46: 173-91. doi: 10.1053/j.seminoncol.2019.04.002CampanaLGMiklavčičDBertinoGMarconatoRValpioneSImarisioIElectrochemotherapy of superficial tumors – Current status: Basic principles, operating procedures, shared indications, and emerging applications2019461739110.1053/j.seminoncol.2019.04.00231122761Open DOISearch in Google Scholar
Bertino G, Sersa G, De Terlizzi F, Occhini A, Plaschke CC, Groselj A, et al. European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer. Eur J Cancer 2016; 63: 41-52. doi: 10.1016/j.ejca.2016.05.001BertinoGSersaGDe TerlizziFOcchiniAPlaschkeCCGroseljAEuropean Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results of the treatment of skin cancer201663415210.1016/j.ejca.2016.05.00127267144Open DOISearch in Google Scholar
Groselj A, Krzan M, Kosjek T, Bosnjak M, Sersa G, Cemazar M. Bleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy. Cancer Chemother Pharmacol 2016; 77: 939-47. doi: 10.1007/s00280-016-3004-zGroseljAKrzanMKosjekTBosnjakMSersaGCemazarMBleomycin pharmacokinetics of bolus bleomycin dose in elderly cancer patients treated with electrochemotherapy2016779394710.1007/s00280-016-3004-z26992379Open DOISearch in Google Scholar
Rotunno R, Campana LG, Quaglino P, De Terlizzi F, Kunte C, Odili J, et al. Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry. J Eur Acad Dermatol Venereol 2018; 32: 1147-54. doi: 10.1111/jdv.14708RotunnoRCampanaLGQuaglinoPDe TerlizziFKunteCOdiliJElectrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry20183211475410.1111/jdv.1470829178483Open DOISearch in Google Scholar
Groselj A, Bosnjak M, Strojan P, Krzan M, Cemazar M, Sersa G. Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results. Head Neck 2018, 40: 120-5. doi: 10.1002/hed.24991GroseljABosnjakMStrojanPKrzanMCemazarMSersaGEfficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results201840120510.1002/hed.2499129130624Open DOISearch in Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026EisenhauerEATherassePBogaertsJSchwartzLHSargentDFordRNew response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)2009452284710.1016/j.ejca.2008.10.02619097774Open DOISearch in Google Scholar
Kristiansson S, Reizenstein J, von Beckerath M, Landström F. Long-term follow-up in patients treated with electrochemotherapy for non-melanoma skin cancer in the head and neck area. Acta Otolaryngol 2019; 139: 195-200. doi: 10.1080/00016489.2018.1543950KristianssonSReizensteinJvon BeckerathMLandströmFLong-term follow-up in patients treated with electrochemotherapy for non-melanoma skin cancer in the head and neck area201913919520010.1080/00016489.2018.154395030734631Open DOISearch in Google Scholar
Campana LG, Marconato R, Valpione S, Galuppo S, Alaibac M, Rossi CR, et al. Basal cell carcinoma: 10-year experience with electrochemotherapy. J Transl Med 2017; 15: 122. doi: 10.1186/s12967-017-1225-5CampanaLGMarconatoRValpioneSGaluppoSAlaibacMRossiCRBasal cell carcinoma: 10-year experience with electrochemotherapy20171512210.1186/s12967-017-1225-5545253128569161Open DOISearch in Google Scholar
Mir LM, Gehl J, Sersa G, Collins CG, Garbaya JR, Billarda V et al. Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. EJC Suppl 2006; 4: 14-25. doi: 10.1016/j.ejc-sup.2006.08.003MirLMGehlJSersaGCollinsCGGarbayaJRBillardaVStandard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes20064142510.1016/j.ejc-sup.2006.08.003Open DOISearch in Google Scholar
Bartoš V, Pokorný D, Zacharová O, Haluska P, Doboszová J, Kullová M, et al. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. Acta Dermatovenerol Alp Pannonica Adriat 2011; 20: 67-75. PMID: 21993704BartošVPokornýDZacharováOHaluskaPDoboszováJKullováMRecurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions2011206775PMID: 21993704Search in Google Scholar
Jayaraman SS, Rayhan DJ, Hazany S, Kolodney MS. Mutational landscape of basal cell carcinomas by whole-exome sequencing. J Invest Dermatol 2014; 134: 213-20. doi: 10.1038/jid.2013.276JayaramanSSRayhanDJHazanySKolodneyMSMutational landscape of basal cell carcinomas by whole-exome sequencing20141342132010.1038/jid.2013.27623774526Open DOISearch in Google Scholar
Groselj A, Kranjc S, Bosnjak M, Krzan M, Kosjek T, Prevc A, et al. Vascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy. Basic Clin Pharmacol Toxicol 2018; 123: 247-56. doi: 10.1111/bcpt.13012GroseljAKranjcSBosnjakMKrzanMKosjekTPrevcAVascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy20181232475610.1111/bcpt.1301229573558Open DOISearch in Google Scholar